Search

Hadi S. Armouche

Supervisory Patent Examiner (ID: 10030, Phone: (571)270-3618 , Office: P/2497 )

Most Active Art Unit
2432
Art Unit(s)
2432, 2132, 2409, 2419, 2497, 4117
Total Applications
377
Issued Applications
241
Pending Applications
35
Abandoned Applications
115

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 744347 [patent_doc_number] => 07026130 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-11 [patent_title] => 'Binding protein' [patent_app_type] => utility [patent_app_number] => 10/804879 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 8394 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/026/07026130.pdf [firstpage_image] =>[orig_patent_app_number] => 10804879 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/804879
Binding protein Mar 17, 2004 Issued
Array ( [id] => 5655742 [patent_doc_number] => 20060141477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Use of parvovirus capsid particles in the inhibition of cell proliferation and migration' [patent_app_type] => utility [patent_app_number] => 10/792640 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17996 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20060141477.pdf [firstpage_image] =>[orig_patent_app_number] => 10792640 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/792640
Use of parvovirus capsid particles in the inhibition of cell proliferation and migration Mar 1, 2004 Abandoned
Array ( [id] => 5135930 [patent_doc_number] => 20070077559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Newcastle disease virus administration' [patent_app_type] => utility [patent_app_number] => 10/548057 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3131 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077559.pdf [firstpage_image] =>[orig_patent_app_number] => 10548057 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/548057
Newcastle disease virus administration Mar 1, 2004 Abandoned
Array ( [id] => 7449815 [patent_doc_number] => 20040186273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Prion-binding ligands and methods of using same' [patent_app_type] => new [patent_app_number] => 10/791516 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12226 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186273.pdf [firstpage_image] =>[orig_patent_app_number] => 10791516 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/791516
Prion-binding ligands and methods of using same Feb 29, 2004 Abandoned
Array ( [id] => 7422431 [patent_doc_number] => 20040229298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Methods and compositions for treating cervical cancer' [patent_app_type] => new [patent_app_number] => 10/789102 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 54149 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229298.pdf [firstpage_image] =>[orig_patent_app_number] => 10789102 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/789102
Methods and compositions for treating cervical cancer Feb 26, 2004 Abandoned
Array ( [id] => 7256294 [patent_doc_number] => 20050075484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Construction and use of synthetic constructs encoding syndecan' [patent_app_type] => utility [patent_app_number] => 10/776989 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 34763 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075484.pdf [firstpage_image] =>[orig_patent_app_number] => 10776989 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/776989
Construction and use of synthetic constructs encoding syndecan Feb 10, 2004 Issued
Array ( [id] => 13382 [patent_doc_number] => 07807455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Method to confer cell culture replication activity to different Hepatitis C virus isolates' [patent_app_type] => utility [patent_app_number] => 10/543633 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7939 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807455.pdf [firstpage_image] =>[orig_patent_app_number] => 10543633 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/543633
Method to confer cell culture replication activity to different Hepatitis C virus isolates Feb 8, 2004 Issued
Array ( [id] => 7334915 [patent_doc_number] => 20040132132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Method for identifying biologically active structures of microbial pathogens' [patent_app_type] => new [patent_app_number] => 10/468591 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 12278 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132132.pdf [firstpage_image] =>[orig_patent_app_number] => 10468591 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/468591
Method for identifying biologically active structures of microbial pathogens Feb 5, 2004 Abandoned
Array ( [id] => 7105784 [patent_doc_number] => 20050107591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Cysteine variants of erythropoietin' [patent_app_type] => utility [patent_app_number] => 10/773530 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26771 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107591.pdf [firstpage_image] =>[orig_patent_app_number] => 10773530 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/773530
Cysteine variants of erythropoietin Feb 4, 2004 Issued
Array ( [id] => 7097247 [patent_doc_number] => 20050129705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Modified HCV peptide vaccines' [patent_app_type] => utility [patent_app_number] => 10/770117 [patent_app_country] => US [patent_app_date] => 2004-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17863 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129705.pdf [firstpage_image] =>[orig_patent_app_number] => 10770117 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/770117
Modified HCV peptide vaccines Feb 1, 2004 Issued
Array ( [id] => 1056585 [patent_doc_number] => 06855809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-15 [patent_title] => 'Methods for the simultaneous detection of HCV antigens and HCV antibodies' [patent_app_type] => utility [patent_app_number] => 10/753910 [patent_app_country] => US [patent_app_date] => 2004-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20336 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855809.pdf [firstpage_image] =>[orig_patent_app_number] => 10753910 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/753910
Methods for the simultaneous detection of HCV antigens and HCV antibodies Jan 6, 2004 Issued
Array ( [id] => 7325931 [patent_doc_number] => 20040138418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Epstein Barr virus induced genes' [patent_app_type] => new [patent_app_number] => 10/749990 [patent_app_country] => US [patent_app_date] => 2003-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16378 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138418.pdf [firstpage_image] =>[orig_patent_app_number] => 10749990 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/749990
Epstein Barr virus induced genes Dec 30, 2003 Abandoned
Array ( [id] => 7177698 [patent_doc_number] => 20050123901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Method and device for the rapid clinical diagnosis of hepatitis C virus (HCV) infection in biological samples' [patent_app_type] => utility [patent_app_number] => 10/744375 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3520 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123901.pdf [firstpage_image] =>[orig_patent_app_number] => 10744375 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/744375
Method and device for the rapid clinical diagnosis of hepatitis C virus (HCV) infection in biological samples Dec 18, 2003 Abandoned
Array ( [id] => 5800014 [patent_doc_number] => 20060035212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Molecules inhibiting hepatitis c virus protein synthesis and method for screening same' [patent_app_type] => utility [patent_app_number] => 10/538471 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7663 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035212.pdf [firstpage_image] =>[orig_patent_app_number] => 10538471 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/538471
Molecules inhibiting hepatitis c virus protein synthesis and method for screening same Dec 10, 2003 Abandoned
Array ( [id] => 7673357 [patent_doc_number] => 20040180422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Methods and compositions for controlling valency of phage display' [patent_app_type] => new [patent_app_number] => 10/723981 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27416 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180422.pdf [firstpage_image] =>[orig_patent_app_number] => 10723981 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/723981
Methods and compositions for controlling valency of phage display Nov 25, 2003 Abandoned
Array ( [id] => 7674720 [patent_doc_number] => 20040127398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Long lasting synthetic glucagon like peptide (GLP-1)' [patent_app_type] => new [patent_app_number] => 10/722733 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20427 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127398.pdf [firstpage_image] =>[orig_patent_app_number] => 10722733 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/722733
Long lasting synthetic glucagon like peptide (GLP-1) Nov 24, 2003 Abandoned
Array ( [id] => 7325023 [patent_doc_number] => 20040138100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Long lasting synthetic glucagon like peptide (GLP-1)' [patent_app_type] => new [patent_app_number] => 10/723099 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20428 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138100.pdf [firstpage_image] =>[orig_patent_app_number] => 10723099 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/723099
Long lasting synthetic glucagon like peptide (GLP-1) Nov 24, 2003 Abandoned
Array ( [id] => 6905162 [patent_doc_number] => 20050100557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences' [patent_app_type] => utility [patent_app_number] => 10/722000 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 74453 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100557.pdf [firstpage_image] =>[orig_patent_app_number] => 10722000 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/722000
Attenuated chimeric respiratory syncytial virus Nov 24, 2003 Issued
Array ( [id] => 7199665 [patent_doc_number] => 20040086535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Novel antiviral acitivities of primate theta defensins and mammalian cathelicidins' [patent_app_type] => new [patent_app_number] => 10/721839 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17039 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086535.pdf [firstpage_image] =>[orig_patent_app_number] => 10721839 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/721839
Novel antiviral acitivities of primate theta defensins and mammalian cathelicidins Nov 24, 2003 Abandoned
Array ( [id] => 7322426 [patent_doc_number] => 20040137016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Pre-S protein of hepatitis B virus (HBV) as an adjuvant and a component of HBV vaccine' [patent_app_type] => new [patent_app_number] => 10/720662 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7102 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137016.pdf [firstpage_image] =>[orig_patent_app_number] => 10720662 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/720662
Pre-S protein of hepatitis B virus (HBV) as an adjuvant and a component of HBV vaccine Nov 23, 2003 Abandoned
Menu